Data:
{
"symbol": "GILD",
"price": 152.21,
"marketCap": 188733574143,
"beta": 0.35,
"lastDividend": 3.25,
"range": "108.46-157.29",
"change": 1.28,
"changePercentage": 0.84808,
"volume": 5043887,
"averageVolume": 7102281,
"companyName": "Gilead Sciences, Inc.",
"currency": "USD",
"cik": "0000882095",
"isin": "US3755581036",
"cusip": "375558103",
"exchangeFullName": "NASDAQ Global Select",
"exchange": "NASDAQ",
"industry": "Drug Manufacturers - General",
"website": "https://www.gilead.com",
"description": "Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.",
"ceo": "Daniel O'Day",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "17000",
"phone": "650 574 3000",
"address": "333 Lakeside Drive",
"city": "Foster City",
"state": "CA",
"zip": "94404",
"image": "https://images.financialmodelingprep.com/symbol/GILD.png",
"ipoDate": "1992-01-22",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "GILD",
"name": "Gilead Sciences, Inc.",
"price": 152.21,
"changePercentage": 0.84808,
"change": 1.28,
"volume": 5043887,
"dayLow": 149.43,
"dayHigh": 152.735,
"yearHigh": 157.29,
"yearLow": 108.46,
"marketCap": 188733574143,
"priceAvg50": 141.8376,
"priceAvg200": 136.1583,
"exchange": "NASDAQ",
"open": 149.795,
"previousClose": 150.93,
"timestamp": 1790625601,
"quote_spread": {},
"chart_vwap_daily": [
{
"t": "2026-08-18",
"v": 142.9091,
"c": 143.44
},
{
"t": "2026-08-19",
"v": 147.5708,
"c": 147.6
},
{
"t": "2026-08-20",
"v": 144.2848,
"c": 143.44
},
{
"t": "2026-08-21",
"v": 146.2334,
"c": 146.12
},
{
"t": "2026-08-24",
"v": 146.4003,
"c": 146.74
},
{
"t": "2026-08-25",
"v": 148.0787,
"c": 148.77
},
{
"t": "2026-08-26",
"v": 148.3983,
"c": 148.09
},
{
"t": "2026-08-27",
"v": 148.4843,
"c": 148.86
},
{
"t": "2026-08-28",
"v": 145.9338,
"c": 145.68
},
{
"t": "2026-08-31",
"v": 146.1092,
"c": 146.34
},
{
"t": "2026-09-01",
"v": 149.0652,
"c": 149.92
},
{
"t": "2026-09-02",
"v": 149.8011,
"c": 149.61
},
{
"t": "2026-09-03",
"v": 150.7033,
"c": 151.22
},
{
"t": "2026-09-04",
"v": 150.7773,
"c": 150.995
},
{
"t": "2026-09-08",
"v": 146.6301,
"c": 146.64
},
{
"t": "2026-09-09",
"v": 145.7683,
"c": 145.65
},
{
"t": "2026-09-10",
"v": 144.7327,
"c": 144.81
},
{
"t": "2026-09-11",
"v": 143.9666,
"c": 143.72
},
{
"t": "2026-09-14",
"v": 145.8572,
"c": 146.41
},
{
"t": "2026-09-15",
"v": 145.6712,
"c": 146.3
},
{
"t": "2026-09-16",
"v": 147.8308,
"c": 147.68
},
{
"t": "2026-09-17",
"v": 150.083,
"c": 150.89
},
{
"t": "2026-09-18",
"v": 150.3436,
"c": 150.11
},
{
"t": "2026-09-21",
"v": 150.8989,
"c": 150.56
},
{
"t": "2026-09-22",
"v": 152.2168,
"c": 152.67
},
{
"t": "2026-09-23",
"v": 151.5029,
"c": 151.37
},
{
"t": "2026-09-24",
"v": 150.6398,
"c": 149.69
},
{
"t": "2026-09-25",
"v": 149.8745,
"c": 150.93
},
{
"t": "2026-09-28",
"v": 151.6693,
"c": 152.21
}
],
"vwap_summary": {
"days": 29,
"days_above": 17,
"days_below": 12,
"pct_days_above": 59,
"position": "above",
"gap_pct": 0.36,
"streak_days": 2
}
}
Data:
{
"volume": 5043887,
"avgVolume": 7102281,
"short_ratio": [
{
"symbol": "GILD",
"file_date": "2026-09-28",
"date": "20260928",
"short_volume": 489955,
"short_exempt_volume": 15265,
"total_volume": 1689243,
"short_volume_ratio": 0.29,
"signal": "Bullish"
}
],
"volume_profile": {
"poc": 150.89,
"vah": 153.11,
"val": 147.96,
"profile": [
{
"price": 143.25,
"volume": 68883
},
{
"price": 143.43,
"volume": 29099
},
{
"price": 143.61,
"volume": 340328
},
{
"price": 143.78,
"volume": 945311
},
{
"price": 143.96,
"volume": 965086
},
{
"price": 144.14,
"volume": 356755
},
{
"price": 144.32,
"volume": 447893
},
{
"price": 144.49,
"volume": 630093
},
{
"price": 144.67,
"volume": 1074228
},
{
"price": 144.85,
"volume": 1191747
},
{
"price": 145.03,
"volume": 850298
},
{
"price": 145.2,
"volume": 520976
},
{
"price": 145.38,
"volume": 698888
},
{
"price": 145.56,
"volume": 1133049
},
{
"price": 145.74,
"volume": 1907657
},
{
"price": 145.92,
"volume": 1434256
},
{
"price": 146.09,
"volume": 1066932
},
{
"price": 146.27,
"volume": 801230
},
{
"price": 146.45,
"volume": 1270255
},
{
"price": 146.63,
"volume": 503182
},
{
"price": 146.8,
"volume": 664215
},
{
"price": 146.98,
"volume": 301143
},
{
"price": 147.16,
"volume": 289309
},
{
"price": 147.34,
"volume": 812516
},
{
"price": 147.51,
"volume": 467271
},
{
"price": 147.69,
"volume": 494695
},
{
"price": 147.87,
"volume": 259109
},
{
"price": 148.05,
"volume": 751756
},
{
"price": 148.23,
"volume": 1079931
},
{
"price": 148.4,
"volume": 1574469
},
{
"price": 148.58,
"volume": 724602
},
{
"price": 148.76,
"volume": 628310
},
{
"price": 148.94,
"volume": 1066500
},
{
"price": 149.11,
"volume": 1593207
},
{
"price": 149.29,
"volume": 1095664
},
{
"price": 149.47,
"volume": 1924639
},
{
"price": 149.65,
"volume": 2243343
},
{
"price": 149.82,
"volume": 2412651
},
{
"price": 150.0,
"volume": 2412695
},
{
"price": 150.18,
"volume": 2445787
},
{
"price": 150.36,
"volume": 1950056
},
{
"price": 150.54,
"volume": 2624769
},
{
"price": 150.71,
"volume": 3654064
},
{
"price": 150.89,
"volume": 4596438
},
{
"price": 151.07,
"volume": 1708210
},
{
"price": 151.25,
"volume": 2242621
},
{
"price": 151.42,
"volume": 1137318
},
{
"price": 151.6,
"volume": 862856
},
{
"price": 151.78,
"volume": 2230712
},
{
"price": 151.96,
"volume": 1241313
},
{
"price": 152.13,
"volume": 695255
},
{
"price": 152.31,
"volume": 875448
},
{
"price": 152.49,
"volume": 555582
},
{
"price": 152.67,
"volume": 964303
},
{
"price": 152.85,
"volume": 1040497
},
{
"price": 153.02,
"volume": 381879
},
{
"price": 153.2,
"volume": 61556
},
{
"price": 153.38,
"volume": 234665
},
{
"price": 153.56,
"volume": 92038
},
{
"price": 153.73,
"volume": 55240
}
],
"sessions": 20
}
}
Data:
{
"symbol": "GILD",
"marketCap": 188733574143,
"enterpriseValueTTM": 211800574143,
"evToSalesTTM": 6.95431357180851,
"evToOperatingCashFlowTTM": 15.629885185078592,
"evToFreeCashFlowTTM": 16.046713701265247,
"evToEBITDATTM": 333.0197706650943,
"netDebtToEBITDATTM": 36.2688679245283,
"currentRatioTTM": 1.265426497277677,
"incomeQualityTTM": 2.588538681948424,
"grahamNumberTTM": null,
"grahamNetNetTTM": -23.8706757843926,
"taxBurdenTTM": 1.6572890025575449,
"interestBurdenTTM": 1.3709677419354838,
"workingCapitalTTM": 2925000000,
"investedCapitalTTM": 31105000000,
"returnOnAssetsTTM": -0.0656375349459098,
"operatingReturnOnAssetsTTM": -0.028265808405906853,
"returnOnTangibleAssetsTTM": -0.11993337034980567,
"returnOnEquityTTM": -0.16284475717786015,
"returnOnInvestedCapitalTTM": -0.03663174424025321,
"returnOnCapitalEmployedTTM": -0.03893902248187366,
"earningsYieldTTM": -0.01712500455213277,
"freeCashFlowYieldTTM": 0.06993456283511781,
"capexToOperatingCashFlowTTM": 0.025975942734853517,
"capexToDepreciationTTM": 0.2563729060451566,
"capexToRevenueTTM": 0.01155765694772787,
"salesGeneralAndAdministrativeToRevenueTTM": 0.2120107696348831,
"researchAndDevelopementToRevenueTTM": 0.1991725768321513,
"stockBasedCompensationToRevenueTTM": 0.015103756238508011,
"intangiblesToTotalAssetsTTM": 0.45271666464081683,
"averageReceivablesTTM": 4898000000,
"averagePayablesTTM": 659500000,
"averageInventoryTTM": 1933500000,
"daysOfSalesOutstandingTTM": 60.58165878644602,
"daysOfPayablesOutstandingTTM": 39.57053241113078,
"daysOfInventoryOutstandingTTM": 114.66060801029437,
"operatingCycleTTM": 175.24226679674038,
"cashConversionCycleTTM": 135.6717343856096,
"freeCashFlowToEquityTTM": 14484000000,
"freeCashFlowToFirmTTM": 14852974424.55243,
"tangibleAssetValueTTM": -10603000000,
"netCurrentAssetValueTTM": -23673000000,
"grossProfitMarginTTM": 0.795869451011295,
"ebitMarginTTM": -0.046821644339374836,
"ebitdaMarginTTM": 0.020882584712371945,
"operatingProfitMarginTTM": -0.04902153926976622,
"pretaxProfitMarginTTM": -0.06419096401365905,
"continuousOperationsProfitMarginTTM": -0.10638297872340426,
"netProfitMarginTTM": -0.10638297872340426,
"bottomLineProfitMarginTTM": -0.10638297872340426,
"receivablesTurnoverTTM": 6.024925816023739,
"payablesTurnoverTTM": 9.224035608308606,
"inventoryTurnoverTTM": 3.1833077316948284,
"fixedAssetTurnoverTTM": 5.221326932967598,
"assetTurnoverTTM": 0.6169928284915522,
"quickRatioTTM": 1.0882032667876589,
"solvencyRatioTTM": -0.03131479610824605,
"cashRatioTTM": 0.288475499092559,
"priceToEarningsRatioTTM": -58.54230769230771,
"priceToEarningsGrowthRatioTTM": 0.3867155051215105,
"forwardPriceToEarningsGrowthRatioTTM": 0.5552898290908078,
"priceToEarningsDilutedRatioTTM": -57.007490636704155,
"priceToEarningsDilutedGrowthRatioTTM": 0.37214252665312725,
"priceToBookRatioTTM": 15.995690733851879,
"priceToSalesRatioTTM": 6.196925864952719,
"priceToFreeCashFlowRatioTTM": 14.29908130487158,
"priceToOperatingCashFlowRatioTTM": 13.961850047966939,
"debtToAssetsRatioTTM": 0.5317045500587496,
"debtToEquityRatioTTM": 2.21897193101116,
"debtToCapitalRatioTTM": 0.6893418080579923,
"longTermDebtToCapitalRatioTTM": 0.6683118339876613,
"financialLeverageRatioTTM": 4.17331755157254,
"workingCapitalTurnoverRatioTTM": 5.037796708295426,
"operatingCashFlowRatioTTM": 1.2296733212341198,
"operatingCashFlowSalesRatioTTM": 0.4449369582348306,
"freeCashFlowOperatingCashFlowRatioTTM": 0.9740240572651465,
"debtServiceCoverageRatioTTM": -0.19021101992966002,
"interestCoverageRatioTTM": -1.4959919839679359,
"shortTermOperatingCashFlowCoverageRatioTTM": 5.613504556752279,
"operatingCashFlowCoverageRatioTTM": 0.5163072468185629,
"capitalExpenditureCoverageRatioTTM": 38.49715909090909,
"dividendPaidAndCapexCoverageRatioTTM": 3.0658371040723984,
"dividendPayoutRatioTTM": -1.2555555555555555,
"dividendYieldTTM": 0.02135208,
"revenuePerShareTTM": 24.50201126307321,
"netIncomePerShareTTM": -2.6065969428801288,
"interestDebtPerShareTTM": 21.917940466613032,
"cashPerShareTTM": 2.5575221238938055,
"bookValuePerShareTTM": 9.448109412711183,
"tangibleBookValuePerShareTTM": -8.530168946098149,
"shareholdersEquityPerShareTTM": 9.515687851971038,
"operatingCashFlowPerShareTTM": 10.901850362027353,
"capexPerShareTTM": 0.2831858407079646,
"freeCashFlowPerShareTTM": 10.618664521319388,
"netIncomePerEBTTTM": 1.6572890025575449,
"ebtPerEbitTTM": 1.3094440723375753,
"priceToFairValueTTM": 15.995690733851879,
"debtToMarketCapTTM": 0.1390637575703085,
"effectiveTaxRateTTM": -0.6572890025575447,
"enterpriseValueMultipleTTM": 333.0197706650943,
"dividendPerShareTTM": 3.25,
"revenue_history": [
{
"date": "2025",
"revenue": 29442000000
}
],
"dcf": {
"symbol": "GILD",
"date": "2026-09-29",
"dcf": 123.20786783507185,
"Stock Price": 152.21
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "GILD",
"reportedCurrency": "USD",
"cik": "0000882095",
"filingDate": "2026-02-24",
"acceptedDate": "2026-02-24 16:18:35",
"fiscalYear": "2025",
"period": "FY",
"revenue": 29442000000,
"costOfRevenue": 6234000000,
"grossProfit": 23208000000,
"researchAndDevelopmentExpenses": 5799000000,
"generalAndAdministrativeExpenses": 2186000000,
"sellingAndMarketingExpenses": 3522000000,
"sellingGeneralAndAdministrativeExpenses": 5708000000,
"otherExpenses": 0,
"operatingExpenses": 11507000000,
"costAndExpenses": 17741000000,
"netInterestIncome": -675000000,
"interestIncome": 349000000,
"interestExpense": 1024000000,
"depreciationAndAmortization": 2760000000,
"ebitda": 13580000000,
"ebit": 10820000000,
"nonOperatingIncomeExcludingInterest": 881000000,
"operatingIncome": 11701000000,
"totalOtherIncomeExpensesNet": -1905000000,
"incomeBeforeTax": 9796000000,
"incomeTaxExpense": 1286000000,
"netIncomeFromContinuingOperations": 8510000000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": 8510000000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": 8510000000,
"eps": 6.84,
"epsDiluted": 6.78,
"weightedAverageShsOut": 1244000000,
"weightedAverageShsOutDil": 1255000000
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "GILD",
"reportedCurrency": "USD",
"cik": "0000882095",
"filingDate": "2026-02-24",
"acceptedDate": "2026-02-24 16:18:35",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 7564000000,
"shortTermInvestments": 2049000000,
"cashAndShortTermInvestments": 9613000000,
"netReceivables": 4913000000,
"accountsReceivables": 4913000000,
"otherReceivables": 0,
"inventory": 1774000000,
"prepaids": 899000000,
"otherCurrentAssets": 1143000000,
"totalCurrentAssets": 18342000000,
"propertyPlantEquipmentNet": 5606000000,
"goodwill": 8314000000,
"intangibleAssets": 16978000000,
"goodwillAndIntangibleAssets": 25292000000,
"longTermInvestments": 2974000000,
"taxAssets": 1964000000,
"otherNonCurrentAssets": 4845000000,
"totalNonCurrentAssets": 40681000000,
"otherAssets": 0,
"totalAssets": 59023000000,
"totalPayables": 807000000,
"accountPayables": 715000000,
"otherPayables": 92000000,
"accruedExpenses": 4337000000,
"shortTermDebt": 2807000000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 3862000000,
"totalCurrentLiabilities": 11813000000,
"longTermDebt": 22129000000,
"capitalLeaseObligationsNonCurrent": 0,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 402000000,
"otherNonCurrentLiabilities": 2061000000,
"totalNonCurrentLiabilities": 24592000000,
"otherLiabilities": 0,
"capitalLeaseObligations": 0,
"totalLiabilities": 36405000000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 1000000,
"retainedEarnings": 13730000000,
"additionalPaidInCapital": 8932000000,
"accumulatedOtherComprehensiveIncomeLoss": 39000000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 22702000000,
"totalEquity": 22618000000,
"minorityInterest": -84000000,
"totalLiabilitiesAndTotalEquity": 59023000000,
"totalInvestments": 5023000000,
"totalDebt": 24936000000,
"netDebt": 17372000000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "GILD",
"reportedCurrency": "USD",
"cik": "0000882095",
"filingDate": "2026-02-24",
"acceptedDate": "2026-02-24 16:18:35",
"fiscalYear": "2025",
"period": "FY",
"netIncome": 8510000000,
"depreciationAndAmortization": 2760000000,
"deferredIncomeTax": 160000000,
"stockBasedCompensation": 894000000,
"changeInWorkingCapital": -3948000000,
"accountsReceivables": -367000000,
"inventory": -1036000000,
"accountsPayables": -132000000,
"otherWorkingCapital": -2413000000,
"otherNonCashItems": 1643000000,
"netCashProvidedByOperatingActivities": 10019000000,
"investmentsInPropertyPlantAndEquipment": -563000000,
"acquisitionsNet": -1070000000,
"purchasesOfInvestments": -4072000000,
"salesMaturitiesOfInvestments": 909000000,
"otherInvestingActivities": 3000000,
"netCashProvidedByInvestingActivities": -4793000000,
"netDebtIssuance": -1788000000,
"longTermNetDebtIssuance": -1788000000,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": -1514000000,
"netCommonStockIssuance": -1514000000,
"commonStockIssuance": 408000000,
"commonStockRepurchased": -1922000000,
"netPreferredStockIssuance": 0,
"netDividendsPaid": -4003000000,
"commonDividendsPaid": -4003000000,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -440000000,
"netCashProvidedByFinancingActivities": -7745000000,
"effectOfForexChangesOnCash": 92000000,
"netChangeInCash": -2427000000,
"cashAtEndOfPeriod": 7564000000,
"cashAtBeginningOfPeriod": 9991000000,
"operatingCashFlow": 10019000000,
"capitalExpenditure": -563000000,
"freeCashFlow": 9456000000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 152.21,
"rsi": 62.02776814504711,
"sma20": 148.88649999999984,
"sma50": 141.83760000000007,
"sma200": 136.15829999999994,
"adx": 29.97051635674341,
"atr": 3.37,
"atr_pct": 2.21,
"atr_expansion_pct": 2.5,
"di_plus": 24.3,
"di_minus": 12.9,
"high_52w": 155.8,
"low_52w": 110.56,
"structure": {
"ema8": 150.59754530059197,
"ema21": 148.37566973096668,
"ema50": 143.58685129315475,
"ema200": 134.31579831386105,
"ema10": 150.26318341259517,
"ema20": 148.55813315119923,
"ema10_slope_pct": 1.27,
"ema20_slope_pct": 1.24,
"trend_dir": "chop",
"checks": {
"price_above_all": true,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": true,
"adx_over_30": false,
"higher_highs_lows": false,
"lower_highs_lows": false,
"near_21ema": false
},
"dist_21ema_pct": 2.6,
"_no_bars": false,
"macd": {
"macd": 2.49,
"signal": 2.581,
"histogram": -0.091
},
"bollinger": {
"mid": 148.89,
"upper": 154.1,
"lower": 143.68,
"width_pct": 7.0
},
"crossover": {
"fresh_cross": null,
"pre_compressed": null,
"held_above_21": null,
"candles_since": null,
"intraday_support": false
},
"momentum": {
"roc10": 4.0,
"ret_3d": 0.55,
"ret_5d": 1.1,
"roc10_accel": 4.25,
"checks": {
"roc_over_5": false,
"rsi_in_band": true,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": true
},
"volume": {
"rvol": 0.85,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": false
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 1.94,
"checks": {
"beats_spy_all": true,
"beats_sector_10d": true,
"rs_line_at_high": true,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"mcap_2b_to_200b": true,
"dollar_vol_over_10m": true,
"common_stock": true,
"no_earnings_7d": true
},
"avg_dollar_vol": 1081038191.01
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": false,
"iv_contracting": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.5,
"iv_rank": 43.0
}
}
}
}
Data:
{
"prior_day": {
"high": 152.74,
"low": 149.41,
"close": 152.21,
"date": "2026-09-28"
},
"woodie_pivots": {
"PP": 151.64,
"R1": 153.87,
"S1": 150.54,
"R2": 154.97,
"S2": 148.31
},
"swing": {
"high_20d": 154.2,
"low_20d": 142.94,
"high_60d": 154.2,
"low_60d": 127.61
},
"orb": {
"high": 150.94,
"low": 149.41,
"date": "2026-09-28"
},
"vwap": 151.43,
"volume_profile": {
"poc": 150.89,
"vah": 153.11,
"val": 147.96,
"sessions": 20
},
"intraday": {
"h1_trend": "up",
"h1_last": 152.24,
"h1_ema9": 151.26,
"h1_ema21": 150.84,
"m15_trend": "flat",
"m15_last": 151.92,
"m15_ema9": 152.11,
"m15_ema21": 151.73,
"rvol_intraday": 0.89,
"as_of_et": "2026-09-28 15:55"
},
"premarket": {
"date": "2026-09-29",
"high": 151.53,
"low": 151.53,
"last": 151.53,
"volume": 220,
"gap_pct": -0.45,
"path": "08:55 151.53",
"bars": 1,
"last_bar_et": "08:55"
},
"recent_daily": [
{
"d": "2026-08-24",
"o": 145.93,
"h": 146.835,
"l": 144.59,
"c": 146.74,
"v": 6183604.752764
},
{
"d": "2026-08-25",
"o": 146.6,
"h": 148.94,
"l": 145.58,
"c": 148.77,
"v": 4630523.891979
},
{
"d": "2026-08-26",
"o": 148,
"h": 149.6199,
"l": 147.004,
"c": 148.09,
"v": 5259811.533437
},
{
"d": "2026-08-27",
"o": 147.3,
"h": 149.105,
"l": 146.01,
"c": 148.86,
"v": 5014794.891503
},
{
"d": "2026-08-28",
"o": 149.47,
"h": 149.47,
"l": 144.88,
"c": 145.68,
"v": 3946913.490047
},
{
"d": "2026-08-31",
"o": 144.23,
"h": 147.22,
"l": 143.175,
"c": 146.34,
"v": 6594694.156303
},
{
"d": "2026-09-01",
"o": 148.52,
"h": 149.96,
"l": 146.915,
"c": 149.92,
"v": 4870766.76228
},
{
"d": "2026-09-02",
"o": 150,
"h": 152.55,
"l": 148.83,
"c": 149.61,
"v": 4923290.064462
},
{
"d": "2026-09-03",
"o": 150.67,
"h": 151.48,
"l": 148.41,
"c": 151.22,
"v": 4498099.373004
},
{
"d": "2026-09-04",
"o": 149.23,
"h": 151.185,
"l": 149.23,
"c": 150.995,
"v": 6181783.667224
},
{
"d": "2026-09-08",
"o": 146.98,
"h": 148.6491,
"l": 145.45,
"c": 146.64,
"v": 6080502.980818
},
{
"d": "2026-09-09",
"o": 145.46,
"h": 147.68,
"l": 145,
"c": 145.65,
"v": 4583213.920199
},
{
"d": "2026-09-10",
"o": 145.07,
"h": 145.9066,
"l": 143.67,
"c": 144.81,
"v": 6019851.813502
},
{
"d": "2026-09-11",
"o": 145.24,
"h": 145.99,
"l": 143.5,
"c": 143.72,
"v": 4202446.607836
},
{
"d": "2026-09-14",
"o": 144.26,
"h": 146.75,
"l": 143.71,
"c": 146.41,
"v": 4920293.234043
},
{
"d": "2026-09-15",
"o": 144.002,
"h": 146.35,
"l": 142.94,
"c": 146.3,
"v": 4536022.158662
},
{
"d": "2026-09-16",
"o": 146.58,
"h": 149.3,
"l": 146.12,
"c": 147.68,
"v": 5188250.807531
},
{
"d": "2026-09-17",
"o": 148.775,
"h": 151.04,
"l": 146.8901,
"c": 150.89,
"v": 7843647.31909
},
{
"d": "2026-09-18",
"o": 150.56,
"h": 153.23,
"l": 149.57,
"c": 150.11,
"v": 16421966.73873
},
{
"d": "2026-09-21",
"o": 150.11,
"h": 152.095,
"l": 148.22,
"c": 150.56,
"v": 5569448.029263
},
{
"d": "2026-09-22",
"o": 150.645,
"h": 153.2807,
"l": 148.65,
"c": 152.67,
"v": 5082660.466456
},
{
"d": "2026-09-23",
"o": 153.6,
"h": 154.1999,
"l": 150.06,
"c": 151.37,
"v": 6191894.610614
},
{
"d": "2026-09-24",
"o": 151.1,
"h": 152.975,
"l": 149.59,
"c": 149.69,
"v": 5075249.452378
},
{
"d": "2026-09-25",
"o": 150.05,
"h": 151,
"l": 148.02,
"c": 150.93,
"v": 5284284.642532
},
{
"d": "2026-09-28",
"o": 149.795,
"h": 152.74,
"l": 149.41,
"c": 152.21,
"v": 5081993.633074
}
]
}
Data:
{
"sector": "Healthcare",
"etf": "XLV",
"etf_trend": "up",
"etf_r5d": 1.33,
"etf_rvol": 0.8,
"rs_5d": -0.24,
"leading": false
}
Data:
{
"estimates": [
{
"symbol": "GILD",
"date": "2030-12-31",
"revenueLow": 37999545539,
"revenueHigh": 40269969127,
"revenueAvg": 39004324362,
"ebitdaLow": 22586278683,
"ebitdaHigh": 24166890870,
"ebitdaAvg": 23285781682,
"ebitLow": 21169891644,
"ebitHigh": 22750503831,
"ebitAvg": 21869394643,
"netIncomeLow": 15876452812,
"netIncomeHigh": 17119480113,
"netIncomeAvg": 16426556963,
"sgaExpenseLow": 7830700494,
"sgaExpenseHigh": 8298574697,
"sgaExpenseAvg": 8037758813,
"epsAvg": 13.08889,
"epsHigh": 13.64102,
"epsLow": 12.65056,
"numAnalystsRevenue": 10,
"numAnalystsEps": 4
},
{
"symbol": "GILD",
"date": "2029-12-31",
"revenueLow": 35964406925,
"revenueHigh": 38113233620,
"revenueAvg": 36915372890,
"ebitdaLow": 21109541991,
"ebitdaHigh": 22563125596,
"ebitdaAvg": 21752823672,
"ebitLow": 19547292999,
"ebitHigh": 21000876604,
"ebitAvg": 20190574680,
"netIncomeLow": 14600406461,
"netIncomeHigh": 15743535762,
"netIncomeAvg": 15106296962,
"sgaExpenseLow": 7411312295,
"sgaExpenseHigh": 7854128598,
"sgaExpenseAvg": 7607281208,
"epsAvg": 12.03689,
"epsHigh": 12.54465,
"epsLow": 11.63379,
"numAnalystsRevenue": 10,
"numAnalystsEps": 4
},
{
"symbol": "GILD",
"date": "2028-12-31",
"revenueLow": 32289467128,
"revenueHigh": 37548019480,
"revenueAvg": 34409388116,
"ebitdaLow": 17341022693,
"ebitdaHigh": 22166082127,
"ebitdaAvg": 19464936528,
"ebitLow": 15585293844,
"ebitHigh": 20410353278,
"ebitAvg": 17709207679,
"netIncomeLow": 11484605409,
"netIncomeHigh": 15279135562,
"netIncomeAvg": 13154896770,
"sgaExpenseLow": 6654004478,
"sgaExpenseHigh": 7737652925,
"sgaExpenseAvg": 7090864080,
"epsAvg": 10.66405,
"epsHigh": 12.17461,
"epsLow": 9.15108,
"numAnalystsRevenue": 21,
"numAnalystsEps": 10
},
{
"symbol": "GILD",
"date": "2027-12-31",
"revenueLow": 31685419690,
"revenueHigh": 33359933959,
"revenueAvg": 32698149877,
"ebitdaLow": 18017408572,
"ebitdaHigh": 20714164743,
"ebitdaAvg": 18602884249,
"ebitLow": 16006451046,
"ebitHigh": 18703207217,
"ebitAvg": 16591926723,
"netIncomeLow": 11815812459,
"netIncomeHigh": 13936599311,
"netIncomeAvg": 12276243080,
"sgaExpenseLow": 6529526290,
"sgaExpenseHigh": 6874599357,
"sgaExpenseAvg": 6738223175,
"epsAvg": 9.92799,
"epsHigh": 11.10486,
"epsLow": 9.41499,
"numAnalystsRevenue": 18,
"numAnalystsEps": 16
}
],
"price_target": {
"symbol": "GILD",
"targetHigh": 175,
"targetLow": 123,
"targetConsensus": 150,
"targetMedian": 150
},
"ratings": {
"symbol": "GILD",
"rating": "C-",
"overallScore": 1,
"discountedCashFlowScore": 4,
"returnOnEquityScore": 1,
"returnOnAssetsScore": 1,
"debtToEquityScore": 1,
"priceToEarningsScore": 1,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "GILD",
"date": "2026-09-10",
"gradingCompany": "HSBC",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-08-05",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-08-05",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-08-05",
"gradingCompany": "Cantor Fitzgerald",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-07-29",
"gradingCompany": "Barclays",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-07-27",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-07-21",
"gradingCompany": "Leerink Partners",
"previousGrade": "Outperform",
"newGrade": "Market Perform",
"action": "downgrade"
},
{
"symbol": "GILD",
"date": "2026-07-08",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-07-07",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-07-07",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-07-06",
"gradingCompany": "Cantor Fitzgerald",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-07-06",
"gradingCompany": "HSBC",
"previousGrade": "Hold",
"newGrade": "Buy",
"action": "upgrade"
},
{
"symbol": "GILD",
"date": "2026-06-16",
"gradingCompany": "Cantor Fitzgerald",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-05-20",
"gradingCompany": "Maxim Group",
"previousGrade": "Hold",
"newGrade": "Buy",
"action": "upgrade"
},
{
"symbol": "GILD",
"date": "2026-05-08",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-05-08",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-04-13",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-04-10",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-02-23",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-02-11",
"gradingCompany": "Scotiabank",
"previousGrade": "Sector Outperform",
"newGrade": "Sector Outperform",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-02-11",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-02-11",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-02-11",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-02-11",
"gradingCompany": "Cantor Fitzgerald",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-02-11",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-01-27",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-01-27",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-01-26",
"gradingCompany": "UBS",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-01-13",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2026-01-07",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2025-12-12",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2025-12-10",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2025-11-13",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2025-11-03",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2025-10-31",
"gradingCompany": "Cantor Fitzgerald",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2025-10-31",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2025-10-31",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2025-10-31",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2025-10-31",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2025-10-23",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "GILD",
"date": "2025-10-08",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Gilead Sciences, Inc. (NASDAQ:GILD) Stock Has Average Price Target of $158.78 According to Analysts",
"url": "https://www.defenseworld.net/2026/09/26/gilead-sciences-inc-nasdaqgild-stock-has-average-price-target-of-158-78-according-to-analysts.html",
"source": "Defense World",
"date": "2026-09-26 04:31:11",
"summary": "Gilead Sciences, Inc. (NASDAQ: GILD - Get Free Report) has been assigned a consensus rating of \"Moderate Buy\" from the twenty-nine research firms that are covering the stock, MarketBeat.com reports. Five research analysts have rated the stock with a hold rating, twenty-three have",
"image": "https://images.financialmodelingprep.com/news/gilead-sciences-inc-nasdaqgild-stock-has-average-price-target-20260926.jpg"
},
{
"title": "Genetic discovery yields clues toward reversal of Alzheimer's brain damage",
"url": "https://www.reuters.com/business/healthcare-pharmaceuticals/genetic-discovery-yields-clues-toward-reversal-alzheimers-brain-damage-2026-09-25/",
"source": "Reuters",
"date": "2026-09-25 07:15:33",
"summary": "Today we highlight a discovery with potentially important implications for future Alzheimer's research and treatments. We also report on an experimental Gilead therapy showing great promise \u200bagainst a difficult-to-treat form of blood cancer, and an interesting new method for stud",
"image": "https://images.financialmodelingprep.com/news/genetic-discovery-yields-clues-toward-reversal-of-alzheimers-brain-20260925.jpg"
},
{
"title": "NTHM's Index Rebalance Puts Thematic Rotation to Work",
"url": "https://www.etftrends.com/thematic-investing-content-hub/nthm-index-rebalance-works-thematic-rotation/",
"source": "ETF Trends",
"date": "2026-09-25 07:06:19",
"summary": "The latest rebalance of VettaFi's Thematic Rotation Quality Momentum Screened Index (TQRMS), tracked by the NBI Thematic Rotation ETF (NTHM:TSX), reshapes the portfolio around a new set of themes. GLP-1 weight loss drug manufacturers and midstream energy join the index, while bat",
"image": "https://images.financialmodelingprep.com/news/nthms-index-rebalance-puts-thematic-rotation-to-work-20260925.jpg"
},
{
"title": "Gilead Sciences, Inc. $GILD Stake Decreased by Envestnet Asset Management Inc.",
"url": "https://www.defenseworld.net/2026/09/25/gilead-sciences-inc-gild-stake-decreased-by-envestnet-asset-management-inc.html",
"source": "Defense World",
"date": "2026-09-25 03:15:49",
"summary": "Envestnet Asset Management Inc. reduced its stake in shares of Gilead Sciences, Inc. (NASDAQ: GILD) by 5.9% in the second quarter, according to its most recent filing with the SEC. The fund owned 1,749,512 shares of the biopharmaceutical company's stock after selling 109,500 shar",
"image": "https://images.financialmodelingprep.com/news/gilead-sciences-inc-gild-stake-decreased-by-envestnet-asset-20260925.jpg"
},
{
"title": "Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH",
"url": "https://www.fool.com/coverage/etfs/2026/09/22/better-healthcare-etf-invesco-s-biotech-focused-ibbq-vs-ishares-broad-iyh/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-09-23T02:04:16Z",
"summary": "The Invesco Nasdaq Biotechnology ETF (IBBQ) offers lower costs (0.19% expense ratio) and higher 1-year returns (44.6%), making it suitable for growth-focused investors willing to accept volatility. The iShares U.S. Healthcare ETF (IYH) provides broader diversification across 100 ",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F3f28864d917b18e124dc110dee6614eac0a6339c-1401x1251.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Co-development Deals in Pharmaceuticals and Biotechnology 2016-2026 | Pharmaceutical Co-Development Deals Reshape R&D Strategies as Companies Share Risk, Costs and Commercial Opportunities",
"url": "https://www.globenewswire.com/news-release/2026/09/22/3366610/28124/en/co-development-deals-in-pharmaceuticals-and-biotechnology-2016-2026-pharmaceutical-co-development-deals-reshape-r-d-strategies-as-companies-share-risk-costs-and-commercial-opportun.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-22T14:59:00Z",
"summary": "A comprehensive market research report analyzing co-development deals in pharmaceuticals and biotechnology from 2016-2026 has been released. The report covers deal structures, financial terms, the top 25 most active dealmakers, and provides access to actual SEC-filed contract doc",
"image": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7"
},
{
"title": "BMY vs GILD: Which Biotech Stock Looks More Attractive Now?",
"url": "https://www.zacks.com/stock/news/2993100/bmy-vs-gild-which-biotech-stock-looks-more-attractive-now?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2993100",
"source": "Zacks Investment Research",
"date": "2026-09-21 12:56:04",
"summary": "Bristol Myers' growth portfolio and pipeline advances offer multiple ways to offset legacy-product erosion, while valuation and leverage remain key factors.",
"image": "https://images.financialmodelingprep.com/news/bmy-vs-gild-which-biotech-stock-looks-more-attractive-20260921.jpg"
},
{
"title": "Can AstraZeneca's Broad Pipeline Offset Recent Setbacks?",
"url": "https://www.zacks.com/stock/news/2991905/can-astrazeneca-s-broad-pipeline-offset-recent-setbacks?cid=CS-ZC-FT-analyst_blog|quick_take-2991905",
"source": "Zacks Investment Research",
"date": "2026-09-18T13:23:00Z",
"summary": "AstraZeneca's stock has declined following several late-stage pipeline failures including Wainua in ATTR-CM, Ultomiris in HSCT-TMA, volrustomig in NSCLC, and Etcamah in breast cancer. However, the company maintains a broad pipeline with over 20 expected high-value readouts in the",
"image": "https://staticx-tuner.zacks.com/images/articles/main/39/612.jpg"
},
{
"title": "J&J Up 18% in Three Months: Buy, Sell or Hold the Stock?",
"url": "https://www.zacks.com/stock/news/2991871/j-j-up-18-in-three-months-buy-sell-or-hold-the-stock?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2991871",
"source": "Zacks Investment Research",
"date": "2026-09-18T13:05:00Z",
"summary": "Johnson & Johnson's stock has risen 18.3% in three months, driven by strong Innovative Medicine segment growth (6.2% organic), successful new drug launches (Icotyde, Imaavy, Inlexzo), and progress on talc litigation resolution. The company targets $100 billion in 2026 revenues an",
"image": "https://staticx-tuner.zacks.com/images/articles/main/12/31139.jpg"
},
{
"title": "Latin America's PAHO-Gilead HIV Prevention Deal Is a Victory for Civil Society, says AHF",
"url": "https://www.businesswire.com/news/home/20260917065835/en/Latin-America%E2%80%99s-PAHO-Gilead-HIV-Prevention-Deal-Is-a-Victory-for-Civil-Society-says-AHF/",
"source": "Business Wire",
"date": "2026-09-17 18:36:00",
"summary": "MEXICO CITY--(BUSINESS WIRE)-- #Gilead--AIDS Healthcare Foundation (AHF), the world's largest HIV care provider, welcomes a new agreement between Gilead Sciences and the Pan American Health Organization (PAHO) that could expand access to lenacapavir for HIV prevention in 14 count",
"image": "https://images.financialmodelingprep.com/news/latin-americas-pahogilead-hiv-prevention-deal-is-a-victory-20260917.jpg"
},
{
"title": "Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know",
"url": "https://www.zacks.com/stock/news/2991152/investors-heavily-search-gilead-sciences-inc-gild-here-is-what-you-need-to-know?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|most_searched_stocks_v1-2991152",
"source": "Zacks Investment Research",
"date": "2026-09-17 10:01:11",
"summary": "Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.",
"image": "https://images.financialmodelingprep.com/news/investors-heavily-search-gilead-sciences-inc-gild-here-is-20260917.jpg"
},
{
"title": "Should You Invest in the VanEck Biotech ETF (BBH)?",
"url": "https://www.zacks.com/stock/news/2990326/should-you-invest-in-the-vaneck-biotech-etf-bbh?cid=CS-ZC-FT-sector_etf-2990326",
"source": "Zacks Investment Research",
"date": "2026-09-16T10:20:02Z",
"summary": "The VanEck Biotech ETF (BBH) offers low-cost exposure to the biotech sector with a 0.35% expense ratio and $462.7 million in assets. The fund tracks the MVIS US Listed Biotech 25 Index and holds 26 companies with top holdings including Amgen, Gilead Sciences, and Vertex Pharmaceu",
"image": "https://staticx-tuner.zacks.com/images/default_article_images/default14.jpg"
},
{
"title": "CAR T-Cell Therapy for Non-Hodgkin\u2019s Lymphoma Market Set for Expansion Through 2036, Fueled by Treatment Innovation and Rising Patient Demand",
"url": "https://www.globenewswire.com/news-release/2026/09/16/3362937/28124/en/car-t-cell-therapy-for-non-hodgkin-s-lymphoma-market-set-for-expansion-through-2036-fueled-by-treatment-innovation-and-rising-patient-demand.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-16T08:55:00Z",
"summary": "The CAR T-cell therapy market for non-Hodgkin's lymphoma is projected to grow at a 7% CAGR from 2026 to 2036, reaching from a 2025 valuation of $3.20 billion across seven major markets. Growth is driven by broader clinical adoption, new indications, earlier-line use, and innovati",
"image": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7"
},
{
"title": "CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market Set for Strong Growth Through 2036, Driven by Next-Generation Innovation and Expanding Patient Access",
"url": "https://www.globenewswire.com/news-release/2026/09/16/3362936/28124/en/car-t-cell-therapy-for-acute-lymphoblastic-leukemia-market-set-for-strong-growth-through-2036-driven-by-next-generation-innovation-and-expanding-patient-access.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-16T08:54:00Z",
"summary": "The CAR-T cell therapy market for acute lymphoblastic leukemia (ALL) is projected to grow at a 6.8% CAGR from 2026 to 2036, reaching from $300 million in 2025. The market is driven by approved therapies like KYMRIAH, TECARTUS, and AUCATZYL, with emerging innovations including all",
"image": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7"
},
{
"title": "Gilead Expands Lenacapavir Access With New PAHO Deal in Latin America",
"url": "https://www.zacks.com/stock/news/2990646/gilead-expands-lenacapavir-access-with-new-paho-deal-in-latin-america?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-2990646",
"source": "Zacks Investment Research",
"date": "2026-09-16 11:31:01",
"summary": "GILD's PAHO deal expands twice-yearly lenacapavir access across Latin America and the Caribbean, adding 14 countries to its global access strategy.",
"image": "https://images.financialmodelingprep.com/news/gilead-expands-lenacapavir-access-with-new-paho-deal-in-20260916.jpg"
},
{
"title": "Gilead Accelerates Global Access Planning for Investigational Once-Yearly Lenacapavir for HIV Prevention",
"url": "https://www.businesswire.com/news/home/20260916123411/en/Gilead-Accelerates-Global-Access-Planning-for-Investigational-Once-Yearly-Lenacapavir-for-HIV-Prevention/",
"source": "Business Wire",
"date": "2026-09-16 08:30:00",
"summary": "FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has expanded the scope of its six royalty-free voluntary licensing agreements for lenacapavir to include investigational once-yearly lenacapavir for HIV prevention as pre-exposure p",
"image": "https://images.financialmodelingprep.com/news/gilead-accelerates-global-access-planning-for-investigational-onceyearly-lenacapavir-20260916.jpg"
},
{
"title": "VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits?",
"url": "https://www.fool.com/coverage/etfs/2026/09/15/vaneck-pharmaceutical-etf-vs-vaneck-biotech-etf-which-fund-is-better-for-drug-innovation-profits/",
"source": "Fool - Investing News",
"date": "2026-09-15 18:44:01",
"summary": "PPH offers higher income and lower volatility, while BBH delivers stronger growth but with deeper drawdowns.",
"image": "https://images.financialmodelingprep.com/news/vaneck-pharmaceutical-etf-vs-vaneck-biotech-etf-which-fund-20260915.jpg"
},
{
"title": "Gilead Sciences Sees Yeztugo Powering HIV Growth as Oncology Pipeline Advances",
"url": "https://www.marketbeat.com/instant-alerts/event-gilead-sciences-sees-yeztugo-powering-hiv-growth-as-oncology-pipeline-advances-2026-09-15/",
"source": "MarketBeat",
"date": "2026-09-15 14:02:50",
"summary": "Gilead Sciences NASDAQ: GILD executives outlined plans to expand the company's HIV prevention and treatment franchises while advancing oncology and inflammation programs, with Chairman and Chief Executive Officer Dan O'Day describing the company as being at an \u201cinflection point i",
"image": "https://images.financialmodelingprep.com/news/gilead-sciences-sees-yeztugo-powering-hiv-growth-as-oncology-20260915.jpg"
},
{
"title": "Gilead Sciences, Inc. (GILD) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript",
"url": "https://seekingalpha.com/article/4946575-gilead-sciences-inc-gild-presents-at-morgan-stanley-24th-annual-global-healthcare-conference",
"source": "Seeking Alpha",
"date": "2026-09-15 13:11:38",
"summary": "Gilead Sciences, Inc. (GILD) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript",
"image": "https://images.financialmodelingprep.com/news/gilead-sciences-inc-gild-presents-at-morgan-stanley-24th-20260915.jpg"
},
{
"title": "Gilead and PAHO Announce Milestone Partnership to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention Across Latin America and the Caribbean",
"url": "https://www.gurufocus.com/news/9082251/gilead-and-paho-announce-milestone-partnership-to-accelerate-access-to-twiceyearly-lenacapavir-for-hiv-prevention-across-latin-america-and-the-caribbean",
"source": "GuruFocus",
"date": "2026-09-15 12:00:00",
"summary": "Gilead Sciences, Inc. (Nasdaq: GILD) today announced a new agreement with the [url=\"]Pan American Health Organization (PAHO)[/url] to accelerate access to twice",
"image": "https://images.financialmodelingprep.com/news/gilead-and-paho-announce-milestone-partnership-to-accelerate-access-20260915.png"
},
{
"title": "Gilead, PAHO agree on HIV prevention drug access in Latin America, Caribbean",
"url": "https://www.reuters.com/legal/litigation/gilead-paho-agree-hiv-prevention-drug-access-latin-america-caribbean-2026-09-15/",
"source": "Reuters",
"date": "2026-09-15 11:11:42",
"summary": "U.S. drugmaker Gilead Sciences said on Tuesday it had reached an agreement with the Pan American Health Organization to \u200bwiden access to its HIV prevention drug across Latin \u200cAmerica and the Caribbean, as the regions seek to curb new infections.",
"image": "https://images.financialmodelingprep.com/news/gilead-paho-agree-on-hiv-prevention-drug-access-in-20260915.jpg"
},
{
"title": "GSK's Specialty Medicines Drive Growth Amid Looming HIV Patent Cliff",
"url": "https://www.zacks.com/stock/news/2987850/gsk-s-specialty-medicines-drive-growth-amid-looming-hiv-patent-cliff?cid=CS-ZC-FT-analyst_blog|quick_take-2987850",
"source": "Zacks Investment Research",
"date": "2026-09-10T15:35:00Z",
"summary": "GSK's Specialty Medicines segment, accounting for over 40% of sales, grew 14% in H1 2026 driven by HIV, respiratory, and oncology products. The company is accelerating R&D with over 20 phase III starts planned for 2026. However, GSK faces a significant challenge as dolutegravir p",
"image": "https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg"
},
{
"title": "Will The Recent Pipeline Progress Boost BMY's Portfolio Expansion?",
"url": "https://www.zacks.com/stock/news/2987100/will-the-recent-pipeline-progress-boost-bmy-s-portfolio-expansion?cid=CS-ZC-FT-analyst_blog|quick_take-2987100",
"source": "Zacks Investment Research",
"date": "2026-09-09T15:14:00Z",
"summary": "Bristol Myers Squibb announced positive Phase II results for arlo-cel, a first-in-class GPRC5D-directed CAR T cell therapy, in heavily pretreated multiple myeloma patients. The QUINTESSENTIAL study met its primary endpoint showing statistically significant overall response rates ",
"image": "https://staticx-tuner.zacks.com/images/articles/main/b7/2106.jpg"
},
{
"title": "Monoclonal Antibodies Market to Grow at 11.01% CAGR, Reaching USD 791.28 Billion by 2035 \u2013 SNS Insider",
"url": "https://www.globenewswire.com/news-release/2026/09/09/3358267/0/en/monoclonal-antibodies-market-to-grow-at-11-01-cagr-reaching-usd-791-28-billion-by-2035-sns-insider.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-09T00:30:00Z",
"summary": "The global monoclonal antibodies market is projected to grow from USD 280.15 billion in 2025 to USD 791.28 billion by 2035, driven by increasing demand for targeted therapies in oncology, autoimmune disorders, and chronic diseases. North America leads with 41% market share, while",
"image": "https://ml.globenewswire.com/Resource/Download/d6272c2e-d204-41b8-b545-a6e2e24f85c2"
},
{
"title": "Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Domain | DelveInsight",
"url": "https://www.globenewswire.com/news-release/2026/09/08/3358009/0/en/chronic-myeloid-leukemia-clinical-trial-pipeline-appears-robust-with-25-key-pharma-companies-actively-working-in-the-domain-delveinsight.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-08T17:00:00Z",
"summary": "The chronic myeloid leukemia (CML) clinical trial pipeline shows robust activity with 25+ pharmaceutical companies developing 25+ pipeline drugs. Key players including Merck, Enliven Therapeutics, ImmunoForge, and others are advancing promising therapies like TERN-701, ELVN-001, ",
"image": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db"
}
]
Data:
[
{
"symbol": "GILD",
"date": "2026-10-29",
"epsActual": null,
"epsEstimated": 2.12,
"revenueActual": null,
"revenueEstimated": 7765691000,
"lastUpdated": "2026-09-29"
},
{
"symbol": "GILD",
"date": "2026-08-04",
"epsActual": -6.75,
"epsEstimated": -7.25,
"revenueActual": 7803000000,
"revenueEstimated": 7398663000,
"lastUpdated": "2026-09-29"
},
{
"symbol": "GILD",
"date": "2026-05-07",
"epsActual": 2.03,
"epsEstimated": 1.91,
"revenueActual": 6960000000,
"revenueEstimated": 6913380000,
"lastUpdated": "2026-08-07"
},
{
"symbol": "GILD",
"date": "2026-02-10",
"epsActual": 1.86,
"epsEstimated": 1.81,
"revenueActual": 7925000000,
"revenueEstimated": 7690358000,
"lastUpdated": "2026-05-10"
},
{
"symbol": "GILD",
"date": "2025-10-30",
"epsActual": 2.47,
"epsEstimated": 2.13,
"revenueActual": 7769000000,
"revenueEstimated": 7445378059,
"lastUpdated": "2026-01-30"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "GILD",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "GILD",
"periods": [
{
"file_period": "202606b",
"settlement_date": "20260622",
"quantity_fails": 39,
"price": 123.76
},
{
"file_period": "202607a",
"settlement_date": "20260714",
"quantity_fails": 473,
"price": 131.4
},
{
"file_period": "202607b",
"settlement_date": "20260730",
"quantity_fails": 199,
"price": 132.73
},
{
"file_period": "202608a",
"settlement_date": "20260811",
"quantity_fails": 701,
"price": 133.06
},
{
"file_period": "202608b",
"settlement_date": "20260824",
"quantity_fails": 2100,
"price": 146.12
},
{
"file_period": "202609a",
"settlement_date": "20260910",
"quantity_fails": 1300,
"price": 145.65
}
],
"trend": "rising",
"trend_description": "FTD quantity increasing \u2014 settlement pressure building, potential squeeze precursor"
}
}
Data:
{
"insider": [
{
"symbol": "GILD",
"filingDate": "2026-09-23",
"transactionDate": "2026-09-22",
"reportingCik": "0001927648",
"companyCik": "0000882095",
"transactionType": "M-Exempt",
"securitiesOwned": 9022,
"reportingName": "Burkhart Erin",
"typeOfOwner": "officer: SVP, Controllership",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2223,
"price": 0,
"securityName": "Restricted Stock Unit",
"url": "https://www.sec.gov/Archives/edgar/data/882095/000192764826000005/0001927648-26-000005-index.htm"
},
{
"symbol": "GILD",
"filingDate": "2026-09-23",
"transactionDate": "2026-09-22",
"reportingCik": "0001927648",
"companyCik": "0000882095",
"transactionType": "M-Exempt",
"securitiesOwned": 2223,
"reportingName": "Burkhart Erin",
"typeOfOwner": "officer: SVP, Controllership",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2223,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/882095/000192764826000005/0001927648-26-000005-index.htm"
},
{
"symbol": "GILD",
"filingDate": "2026-09-23",
"transactionDate": "2026-09-22",
"reportingCik": "0001927648",
"companyCik": "0000882095",
"transactionType": "F-InKind",
"securitiesOwned": 1455,
"reportingName": "Burkhart Erin",
"typeOfOwner": "officer: SVP, Controllership",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 768,
"price": 152.67,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/882095/000192764826000005/0001927648-26-000005-index.htm"
},
{
"symbol": "GILD",
"filingDate": "2026-09-16",
"transactionDate": "2026-09-15",
"reportingCik": "0001310204",
"companyCik": "0000882095",
"transactionType": "S-Sale",
"securitiesOwned": 164096,
"reportingName": "Dickinson Andrew D",
"typeOfOwner": "officer: Chief Financial Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 3000,
"price": 145.29,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/882095/000131020426000029/0001310204-26-000029-index.htm"
},
{
"symbol": "GILD",
"filingDate": "2026-09-16",
"transactionDate": "2026-09-15",
"reportingCik": "0001782135",
"companyCik": "0000882095",
"transactionType": "S-Sale",
"securitiesOwned": 118084,
"reportingName": "Mercier Johanna",
"typeOfOwner": "officer: Chief Comm & Corp Aff Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1600,
"price": 143.6917,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/882095/000178213526000033/0001782135-26-000033-index.htm"
},
{
"symbol": "GILD",
"filingDate": "2026-09-16",
"transactionDate": "2026-09-15",
"reportingCik": "0001782135",
"companyCik": "0000882095",
"transactionType": "S-Sale",
"securitiesOwned": 117284,
"reportingName": "Mercier Johanna",
"typeOfOwner": "officer: Chief Comm & Corp Aff Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 800,
"price": 144.4569,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/882095/000178213526000033/0001782135-26-000033-index.htm"
},
{
"symbol": "GILD",
"filingDate": "2026-09-16",
"transactionDate": "2026-09-15",
"reportingCik": "0001782135",
"companyCik": "0000882095",
"transactionType": "S-Sale",
"securitiesOwned": 116684,
"reportingName": "Mercier Johanna",
"typeOfOwner": "officer: Chief Comm & Corp Aff Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 600,
"price": 145.29,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/882095/000178213526000033/0001782135-26-000033-index.htm"
},
{
"symbol": "GILD",
"filingDate": "2026-09-11",
"transactionDate": "2026-09-10",
"reportingCik": "0001310204",
"companyCik": "0000882095",
"transactionType": "M-Exempt",
"securitiesOwned": 168443,
"reportingName": "Dickinson Andrew D",
"typeOfOwner": "officer: Chief Financial Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2797,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/882095/000131020426000027/0001310204-26-000027-index.htm"
}
],
"congress": [
{
"symbol": "GILD",
"senateID": "T000278",
"disclosureDate": "2026-08-05",
"transactionDate": "2024-05-10",
"firstName": "Thomas Hawley",
"lastName": "Tuberville",
"office": "Tommy Tuberville",
"district": "AL",
"owner": "Joint",
"assetDescription": "Gilead Sciences Inc (2)",
"assetType": "Stock Option",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/0a25588d-a3f8-4ed6-971a-706097f78e3a/"
},
{
"symbol": "GILD",
"senateID": "T000278",
"disclosureDate": "2026-08-05",
"transactionDate": "2024-05-10",
"firstName": "Thomas Hawley",
"lastName": "Tuberville",
"office": "Tommy Tuberville",
"district": "AL",
"owner": "Joint",
"assetDescription": "Gilead Sciences Inc (1)",
"assetType": "Stock Option",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/0a25588d-a3f8-4ed6-971a-706097f78e3a/"
},
{
"symbol": "GILD",
"senateID": "T000278",
"disclosureDate": "2026-08-05",
"transactionDate": "2024-05-10",
"firstName": "Thomas Hawley",
"lastName": "Tuberville",
"office": "Tommy Tuberville",
"district": "AL",
"owner": "Joint",
"assetDescription": "Gilead Sciences Inc (3)",
"assetType": "Stock Option",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/0a25588d-a3f8-4ed6-971a-706097f78e3a/"
},
{
"symbol": "GILD",
"senateID": "B001236",
"disclosureDate": "2025-05-14",
"transactionDate": "2025-04-16",
"firstName": "John",
"lastName": "Boozman",
"office": "John Boozman",
"district": "AR",
"owner": "Joint",
"assetDescription": "Gilead Sciences Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/52c9fa8c-a4fa-4f74-9013-0e1076574cfa/"
},
{
"symbol": "GILD",
"senateID": "B001236",
"disclosureDate": "2025-05-14",
"transactionDate": "2025-04-16",
"firstName": "John",
"lastName": "Boozman",
"office": "John Boozman",
"district": "AR",
"owner": "Joint",
"assetDescription": "Gilead Sciences Inc",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "--",
"link": "https://efdsearch.senate.gov/search/view/ptr/52c9fa8c-a4fa-4f74-9013-0e1076574cfa/"
},
{
"symbol": "GILD",
"senateID": "T000278",
"disclosureDate": "2024-06-14",
"transactionDate": "2024-05-10",
"firstName": "Thomas Hawley",
"lastName": "Tuberville",
"office": "Thomas H Tuberville",
"district": "AL",
"owner": "Joint",
"assetDescription": "Gilead Sciences Inc",
"assetType": "Stock Option",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/b5272e54-0ad8-462c-97f5-9af1ea47b1f1/"
},
{
"symbol": "GILD",
"senateID": "T000278",
"disclosureDate": "2024-06-14",
"transactionDate": "2024-05-08",
"firstName": "Thomas Hawley",
"lastName": "Tuberville",
"office": "Thomas H Tuberville",
"district": "AL",
"owner": "Joint",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/b5272e54-0ad8-462c-97f5-9af1ea47b1f1/"
},
{
"symbol": "GILD",
"senateID": "T000278",
"disclosureDate": "2024-05-15",
"transactionDate": "2024-04-03",
"firstName": "Thomas Hawley",
"lastName": "Tuberville",
"office": "Tommy Tuberville",
"district": "AL",
"owner": "Joint",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock Option",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "--",
"link": "https://efdsearch.senate.gov/search/view/ptr/dda61a64-82ed-4cc8-87e7-ef1d256c6565/"
},
{
"symbol": "GILD",
"senateID": "T000278",
"disclosureDate": "2024-05-15",
"transactionDate": "2024-04-05",
"firstName": "Thomas Hawley",
"lastName": "Tuberville",
"office": "Tommy Tuberville",
"district": "AL",
"owner": "Joint",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "--",
"link": "https://efdsearch.senate.gov/search/view/ptr/dda61a64-82ed-4cc8-87e7-ef1d256c6565/"
},
{
"symbol": "GILD",
"senateID": "T000278",
"disclosureDate": "2022-02-14",
"transactionDate": "2022-01-13",
"firstName": "Thomas Hawley",
"lastName": "Tuberville",
"office": "Thomas H Tuberville",
"district": "AL",
"owner": "Joint",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/c9da6bea-fa14-4a3a-9d8b-1745e834da59/"
},
{
"symbol": "GILD",
"senateID": "M000934",
"disclosureDate": "2022-01-21",
"transactionDate": "2021-12-21",
"firstName": "Jerry",
"lastName": "Moran",
"office": "Jerry Moran",
"district": "KS",
"owner": "Spouse",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/a8e388bc-72c5-4227-b6f3-64b7bb779883/"
},
{
"symbol": "GILD",
"senateID": "M000934",
"disclosureDate": "2022-01-21",
"transactionDate": "2021-12-21",
"firstName": "Jerry",
"lastName": "Moran",
"office": "Jerry Moran",
"district": "KS",
"owner": "Self",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/a8e388bc-72c5-4227-b6f3-64b7bb779883/"
},
{
"symbol": "GILD",
"senateID": "M000934",
"disclosureDate": "2020-09-08",
"transactionDate": "2020-08-21",
"firstName": "Jerry",
"lastName": "Moran",
"office": "Jerry Moran",
"district": "KS",
"owner": "Self",
"assetDescription": "Gilead Sciences, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/5809a671-cb5c-46c3-a6ec-35481814e274/"
},
{
"symbol": "GILD",
"senateID": "M000934",
"disclosureDate": "2020-08-05",
"transactionDate": "2019-09-25",
"firstName": "Jerry",
"lastName": "Moran",
"office": "Jerry Moran",
"district": "KS",
"owner": "Self",
"assetDescription": "Gilead Sciences, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "--",
"link": "https://efdsearch.senate.gov/search/view/ptr/c5faa8f8-b17f-478f-9457-794d602266c3/"
},
{
"symbol": "GILD",
"senateID": "M000934",
"disclosureDate": "2020-08-05",
"transactionDate": "2019-09-25",
"firstName": "Jerry",
"lastName": "Moran",
"office": "Jerry Moran",
"district": "KS",
"owner": "Spouse",
"assetDescription": "Gilead Sciences, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "--",
"link": "https://efdsearch.senate.gov/search/view/ptr/c5faa8f8-b17f-478f-9457-794d602266c3/"
},
{
"symbol": "GILD",
"senateID": "M000934",
"disclosureDate": "2019-10-21",
"transactionDate": "2019-09-25",
"firstName": "Jerry",
"lastName": "Moran",
"office": "Jerry Moran",
"district": "KS",
"owner": "Spouse",
"assetDescription": "Gilead Sciences, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/6dd15e55-0abc-46ee-bbf6-6d543b6f7e90/"
},
{
"symbol": "GILD",
"senateID": "M000934",
"disclosureDate": "2019-10-21",
"transactionDate": "2019-09-25",
"firstName": "Jerry",
"lastName": "Moran",
"office": "Jerry Moran",
"district": "KS",
"owner": "Self",
"assetDescription": "Gilead Sciences, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/6dd15e55-0abc-46ee-bbf6-6d543b6f7e90/"
},
{
"symbol": "GILD",
"senateID": "C001047",
"disclosureDate": "2019-04-17",
"transactionDate": "2019-03-11",
"firstName": "Shelley Moore",
"lastName": "Capito",
"office": "Shelley M Capito",
"district": "WV",
"owner": "Spouse",
"assetDescription": "Gilead Sciences, Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/46cecbcc-7c1c-4cbb-aa4f-fa1d2cd63627/"
},
{
"symbol": "GILD",
"senateID": "C001047",
"disclosureDate": "2018-10-18",
"transactionDate": "2018-09-25",
"firstName": "Shelley Moore",
"lastName": "Capito",
"office": "Shelley M Capito",
"district": "WV",
"owner": "Self",
"assetDescription": "Gilead Sciences, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/ae39aeb9-967e-49eb-be3d-562d7efd2159/"
},
{
"symbol": "GILD",
"senateID": "W000802",
"disclosureDate": "2018-08-10",
"transactionDate": "2017-09-20",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Spouse",
"assetDescription": "Gilead Sciences, Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/9d15724e-997c-4b1a-8b19-e0114f14ee13/"
},
{
"symbol": "GILD",
"senateID": "K000389",
"disclosureDate": "2026-09-07",
"transactionDate": "2026-08-10",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Gilead Sciences Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/9116328.pdf"
},
{
"symbol": "GILD",
"senateID": "K000389",
"disclosureDate": "2026-08-12",
"transactionDate": "2026-07-07",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Gilead Sciences Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/9116267.pdf"
},
{
"symbol": "GILD",
"senateID": "M001217",
"disclosureDate": "2026-06-22",
"transactionDate": "2026-05-06",
"firstName": "Jared",
"lastName": "Moskowitz",
"office": "Jared Moskowitz",
"district": "FL23",
"owner": "",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034749.pdf"
},
{
"symbol": "GILD",
"senateID": "M001217",
"disclosureDate": "2026-06-22",
"transactionDate": "2026-05-06",
"firstName": "Jared",
"lastName": "Moskowitz",
"office": "Jared Moskowitz",
"district": "FL23",
"owner": "Dependent",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034749.pdf"
},
{
"symbol": "GILD",
"senateID": "G000583",
"disclosureDate": "2026-02-27",
"transactionDate": "2026-01-27",
"firstName": "Josh S.",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20033930.pdf"
},
{
"symbol": "GILD",
"senateID": "H001094",
"disclosureDate": "2025-10-10",
"transactionDate": "2025-09-23",
"firstName": "Val",
"lastName": "Hoyle",
"office": "Valerie Hoyle",
"district": "OR04",
"owner": "Spouse",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20032211.pdf"
},
{
"symbol": "GILD",
"senateID": "H001094",
"disclosureDate": "2025-09-12",
"transactionDate": "2024-10-29",
"firstName": "Val",
"lastName": "Hoyle",
"office": "Valerie Hoyle",
"district": "OR04",
"owner": "Spouse",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20032070.pdf"
},
{
"symbol": "GILD",
"senateID": "S001229",
"disclosureDate": "2025-06-23",
"transactionDate": "2025-05-12",
"firstName": "Jefferson",
"lastName": "Shreve",
"office": "Jefferson Shreve",
"district": "IN06",
"owner": "",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030387.pdf"
},
{
"symbol": "GILD",
"senateID": "G000596",
"disclosureDate": "2025-06-19",
"transactionDate": "2025-06-06",
"firstName": "Marjorie Taylor",
"lastName": "Greene",
"office": "Marjorie Taylor Greene",
"district": "GA14",
"owner": "",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030539.pdf"
},
{
"symbol": "GILD",
"senateID": "G000583",
"disclosureDate": "2025-06-12",
"transactionDate": "2025-05-14",
"firstName": "Josh S.",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030462.pdf"
},
{
"symbol": "GILD",
"senateID": "G000596",
"disclosureDate": "2025-05-07",
"transactionDate": "2025-05-05",
"firstName": "Marjorie Taylor",
"lastName": "Greene",
"office": "Marjorie Taylor Greene",
"district": "GA14",
"owner": "",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030295.pdf"
},
{
"symbol": "GILD",
"senateID": "S001229",
"disclosureDate": "2025-04-14",
"transactionDate": "2025-03-31",
"firstName": "Jefferson",
"lastName": "Shreve",
"office": "Jefferson Shreve",
"district": "IN06",
"owner": "",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20029038.pdf"
},
{
"symbol": "GILD",
"senateID": "G000583",
"disclosureDate": "2025-04-11",
"transactionDate": "2025-03-07",
"firstName": "Josh S.",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20029083.pdf"
},
{
"symbol": "GILD",
"senateID": "M001205",
"disclosureDate": "2025-04-11",
"transactionDate": "2025-03-10",
"firstName": "Carol Devine",
"lastName": "Miller",
"office": "Carol Devine Miller",
"district": "WV01",
"owner": "",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20029135.pdf"
},
{
"symbol": "GILD",
"senateID": "G000596",
"disclosureDate": "2024-12-30",
"transactionDate": "2024-12-24",
"firstName": "Marjorie Taylor",
"lastName": "Greene",
"office": "Marjorie Taylor Greene",
"district": "GA14",
"owner": "",
"assetDescription": "Gilead Sciences, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/20026473.pdf"
},
{
"symbol": "GILD",
"senateID": "K000389",
"disclosureDate": "2024-04-05",
"transactionDate": "2024-03-25",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Gilead Sciences Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/8220192.pdf"
},
{
"symbol": "GILD",
"senateID": "K000389",
"disclosureDate": "2024-03-06",
"transactionDate": "2024-02-13",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Gilead Sciences Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/8220173.pdf"
},
{
"symbol": "GILD",
"senateID": "K000389",
"disclosureDate": "2023-12-06",
"transactionDate": "2023-11-03",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Gilead Sciences Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8220067.pdf"
},
{
"symbol": "GILD",
"senateID": "S001211",
"disclosureDate": "2023-11-09",
"transactionDate": "2023-09-26",
"firstName": "Greg",
"lastName": "Stanton",
"office": "Greg Stanton",
"district": "AZ04",
"owner": "Spouse",
"assetDescription": "Gilead Sciences, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20023892.pdf"
},
{
"symbol": "GILD",
"senateID": "S001211",
"disclosureDate": "2023-11-09",
"transactionDate": "2023-10-24",
"firstName": "Greg",
"lastName": "Stanton",
"office": "Greg Stanton",
"district": "AZ04",
"owner": "Spouse",
"assetDescription": "Gilead Sciences, Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20023892.pdf"
}
],
"dark_pool": [
{
"ticker": "GILD",
"executed_at": "2026-09-28T20:10:25.952000Z",
"size": 198768.0,
"price": 152.21,
"premium": 30254477.28,
"volume": 198768.0,
"trade_code": " "
},
{
"ticker": "GILD",
"executed_at": "2026-09-28T20:00:01.493000Z",
"size": 42417.0,
"price": 152.21,
"premium": 6456291.57,
"volume": 42417.0,
"trade_code": " "
},
{
"ticker": "GILD",
"executed_at": "2026-09-28T20:41:03.298000Z",
"size": 34122.0,
"price": 152.21,
"premium": 5193709.62,
"volume": 34122.0,
"trade_code": " "
},
{
"ticker": "GILD",
"executed_at": "2026-09-28T21:25:59.018000Z",
"size": 32213.0,
"price": 152.21,
"premium": 4903140.73,
"volume": 32213.0,
"trade_code": " "
},
{
"ticker": "GILD",
"executed_at": "2026-09-28T20:00:20.291000Z",
"size": 17144.0,
"price": 152.21,
"premium": 2609488.24,
"volume": 17144.0,
"trade_code": " "
},
{
"ticker": "GILD",
"executed_at": "2026-09-28T20:00:30.313000Z",
"size": 15840.0,
"price": 152.21,
"premium": 2411006.4,
"volume": 15840.0,
"trade_code": " "
},
{
"ticker": "GILD",
"executed_at": "2026-09-28T20:00:38.750000Z",
"size": 15157.0,
"price": 152.21,
"premium": 2307046.97,
"volume": 15157.0,
"trade_code": " "
},
{
"ticker": "GILD",
"executed_at": "2026-09-28T20:00:39.838000Z",
"size": 13476.0,
"price": 152.21,
"premium": 2051181.9600000002,
"volume": 13476.0,
"trade_code": " "
}
],
"ats": {
"symbol": "GILD",
"date": "20260928",
"ats_volume": 0,
"total_volume": 1689243,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260928",
"ats_ratio": 0.0
},
{
"date": "20260925",
"ats_ratio": 0.0
},
{
"date": "20260924",
"ats_ratio": 0.0
},
{
"date": "20260923",
"ats_ratio": 0.0
},
{
"date": "20260922",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "GILD",
"days": [
{
"date": "2026-09-28",
"close": 152.21,
"vwap": 151.67,
"volume": 5081993,
"vwap_discount_pct": -0.36
},
{
"date": "2026-09-25",
"close": 150.93,
"vwap": 149.87,
"volume": 5284284,
"vwap_discount_pct": -0.7
},
{
"date": "2026-09-24",
"close": 149.69,
"vwap": 150.64,
"volume": 5075249,
"vwap_discount_pct": 0.63
},
{
"date": "2026-09-23",
"close": 151.37,
"vwap": 151.5,
"volume": 6191894,
"vwap_discount_pct": 0.09
},
{
"date": "2026-09-22",
"close": 152.67,
"vwap": 152.22,
"volume": 5082660,
"vwap_discount_pct": -0.3
}
],
"avg_vwap_discount_pct": -0.13,
"signal": "Neutral"
},
"options_flow": [
{
"volume": 312,
"executed_at": "2026-09-28T19:26:31.199000Z",
"size": 202,
"implied_volatility": "0.3187717545028145",
"delta": "0.518995478245396",
"expiry": "2026-10-02",
"underlying_symbol": "GILD",
"open_interest": 172,
"strike": "152.5",
"nbbo_bid": "1.96",
"option_chain_id": "GILD261002C00152500",
"option_type": "call",
"underlying_price": "152.59",
"sector": "Healthcare",
"premium": "42622.00",
"price": "2.11",
"nbbo_ask": "2.11"
},
{
"volume": 71,
"executed_at": "2026-09-28T19:00:44.763000Z",
"size": 30,
"implied_volatility": "0.2950941878400007",
"delta": "0.61729424910323",
"expiry": "2026-10-16",
"underlying_symbol": "GILD",
"open_interest": 820,
"strike": "150",
"nbbo_bid": "5.40",
"option_chain_id": "GILD261016C00150000",
"option_type": "call",
"underlying_price": "152.33",
"sector": "Healthcare",
"premium": "16200.00",
"price": "5.40",
"nbbo_ask": "5.50"
},
{
"volume": 5,
"executed_at": "2026-09-28T19:00:56.432000Z",
"size": 5,
"implied_volatility": "0.243105008065471",
"delta": "0.968981700093632",
"expiry": "2026-12-18",
"underlying_symbol": "GILD",
"open_interest": 104,
"strike": "125",
"nbbo_bid": "27.35",
"option_chain_id": "GILD261218C00125000",
"option_type": "call",
"underlying_price": "152.33",
"sector": "Healthcare",
"premium": "14360.00",
"price": "28.72",
"nbbo_ask": "30.10"
},
{
"volume": 5,
"executed_at": "2026-09-28T19:00:56.432000Z",
"size": 5,
"implied_volatility": "0.2213413706266718",
"delta": "0.99303128788164",
"expiry": "2026-11-20",
"underlying_symbol": "GILD",
"open_interest": 222,
"strike": "125",
"nbbo_bid": "27.15",
"option_chain_id": "GILD261120C00125000",
"option_type": "call",
"underlying_price": "152.33",
"sector": "Healthcare",
"premium": "14060.00",
"price": "28.12",
"nbbo_ask": "29.10"
}
],
"net_premium": {
"ticker": "GILD",
"net_call_premium": "19372.00",
"net_put_premium": "8012.00",
"call_premium": "1051588.00",
"put_premium": "405591.00",
"bullish_premium": "666868.00",
"bearish_premium": "655508.00",
"put_call_ratio": "0.5559701492537313432835820896",
"iv_rank": "42.804",
"implied_move_perc": "0.06",
"gex_ratio": "0.34952645237333424898",
"gex_net_change": "12585.5323",
"gex_call": "143918.4026",
"gex_put": "-50104.2623",
"gex_net": 93814.1403,
"gex_call_delta": "5669854.9787",
"gex_put_delta": "-806927.6663",
"gex_date": "2026-09-29"
},
"hot_chains": [
{
"open_interest": 405,
"volume": 714,
"last_price": "0.97",
"option_symbol": "GILD261002C00155000",
"ask_volume": 662,
"bid_volume": 40,
"nbbo_bid": "0.44",
"nbbo_ask": "1.27",
"avg_price": "0.8273949579831932773109243700"
},
{
"open_interest": 196,
"volume": 504,
"last_price": "1.05",
"option_symbol": "GILD261002P00150000",
"ask_volume": 480,
"bid_volume": 16,
"nbbo_bid": "0.74",
"nbbo_ask": "1.11",
"avg_price": "1.2617658730158730158730158732"
},
{
"open_interest": 78,
"volume": 393,
"last_price": "0.69",
"option_symbol": "GILD261002P00149000",
"ask_volume": 387,
"bid_volume": 6,
"nbbo_bid": "0.67",
"nbbo_ask": "0.89",
"avg_price": "0.8454707379134860050890585241"
},
{
"open_interest": 172,
"volume": 315,
"last_price": "1.92",
"option_symbol": "GILD261002C00152500",
"ask_volume": 275,
"bid_volume": 37,
"nbbo_bid": "1.01",
"nbbo_ask": "2.72",
"avg_price": "1.9769523809523809523809523808"
},
{
"open_interest": 52,
"volume": 256,
"last_price": "3.72",
"option_symbol": "GILD261023C00155000",
"ask_volume": 251,
"bid_volume": 2,
"nbbo_bid": "2.01",
"nbbo_ask": "3.70",
"avg_price": "3.5605078125000000000000000000"
},
{
"open_interest": 1746,
"volume": 132,
"last_price": "2.58",
"option_symbol": "GILD261016C00155000",
"ask_volume": 81,
"bid_volume": 50,
"nbbo_bid": "2.00",
"nbbo_ask": "3.20",
"avg_price": "2.4159090909090909090909090910"
},
{
"open_interest": 1177,
"volume": 131,
"last_price": "0.39",
"option_symbol": "GILD261002C00157500",
"ask_volume": 84,
"bid_volume": 17,
"nbbo_bid": "0.20",
"nbbo_ask": "0.51",
"avg_price": "0.3893893129770992366412213739"
},
{
"open_interest": 99,
"volume": 127,
"last_price": "0.17",
"option_symbol": "GILD261002C00160000",
"ask_volume": 51,
"bid_volume": 57,
"nbbo_bid": "0.01",
"nbbo_ask": "0.25",
"avg_price": "0.1643307086614173228346456693"
}
],
"gamma_profile": {
"ticker": "GILD",
"spot": 151.53,
"date": "2026-09-29",
"flip_point": 149.25,
"net_gex": 93814.14,
"call_walls": [
{
"strike": 155.0,
"gex": 28435.12
},
{
"strike": 150.0,
"gex": 24357.95
},
{
"strike": 165.0,
"gex": 23161.13
}
],
"put_walls": [
{
"strike": 150.0,
"gex": -9422.05
},
{
"strike": 145.0,
"gex": -4743.74
},
{
"strike": 135.0,
"gex": -4698.37
}
],
"by_strike": [
{
"strike": 139.0,
"call_gex": 0.0,
"put_gex": -211.97,
"net_gex": -211.97
},
{
"strike": 140.0,
"call_gex": 6407.59,
"put_gex": -4415.61,
"net_gex": 1991.97
},
{
"strike": 141.0,
"call_gex": 39.78,
"put_gex": -160.14,
"net_gex": -120.36
},
{
"strike": 142.0,
"call_gex": 108.85,
"put_gex": -741.95,
"net_gex": -633.1
},
{
"strike": 143.0,
"call_gex": 105.59,
"put_gex": -473.26,
"net_gex": -367.67
},
{
"strike": 144.0,
"call_gex": 74.04,
"put_gex": -867.86,
"net_gex": -793.82
},
{
"strike": 145.0,
"call_gex": 7970.38,
"put_gex": -4743.74,
"net_gex": 3226.64
},
{
"strike": 146.0,
"call_gex": 126.1,
"put_gex": -424.4,
"net_gex": -298.31
},
{
"strike": 147.0,
"call_gex": 250.03,
"put_gex": -475.47,
"net_gex": -225.44
},
{
"strike": 148.0,
"call_gex": 2064.82,
"put_gex": -1644.64,
"net_gex": 420.18
},
{
"strike": 149.0,
"call_gex": 690.53,
"put_gex": -3157.9,
"net_gex": -2467.37
},
{
"strike": 150.0,
"call_gex": 24357.95,
"put_gex": -9422.05,
"net_gex": 14935.9
},
{
"strike": 152.5,
"call_gex": 3672.12,
"put_gex": -2057.01,
"net_gex": 1615.11
},
{
"strike": 155.0,
"call_gex": 28435.12,
"put_gex": -1758.19,
"net_gex": 26676.94
},
{
"strike": 157.5,
"call_gex": 7847.11,
"put_gex": -35.92,
"net_gex": 7811.19
},
{
"strike": 160.0,
"call_gex": 13358.17,
"put_gex": -394.55,
"net_gex": 12963.61
},
{
"strike": 162.5,
"call_gex": 776.96,
"put_gex": 0.0,
"net_gex": 776.96
},
{
"strike": 165.0,
"call_gex": 23161.13,
"put_gex": -1283.37,
"net_gex": 21877.75
},
{
"strike": 167.5,
"call_gex": 76.71,
"put_gex": -3.38,
"net_gex": 73.33
},
{
"strike": 170.0,
"call_gex": 3259.38,
"put_gex": -43.96,
"net_gex": 3215.42
},
{
"strike": 172.5,
"call_gex": 16.95,
"put_gex": 0.0,
"net_gex": 16.95
},
{
"strike": 175.0,
"call_gex": 4669.19,
"put_gex": -97.83,
"net_gex": 4571.35
},
{
"strike": 177.5,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 180.0,
"call_gex": 1112.32,
"put_gex": -99.27,
"net_gex": 1013.05
},
{
"strike": 182.5,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
}
]
},
"oi_changes": {
"net_call_oi_change": -45,
"net_put_oi_change": 0,
"top": [
{
"strike": null,
"oi_change": -26,
"type": "call"
},
{
"strike": null,
"oi_change": -25,
"type": "call"
},
{
"strike": null,
"oi_change": 5,
"type": "call"
},
{
"strike": null,
"oi_change": -4,
"type": "call"
},
{
"strike": null,
"oi_change": 3,
"type": "call"
}
]
},
"opds": {
"opds": -5.4,
"D": -13.9,
"P": 24.7,
"O": -3.0,
"C": 38.8,
"signal": "NEUTRAL",
"direction": "bearish",
"coverage": 0.65,
"ranked": true,
"components": {
"M": 18.3,
"T": 41.3,
"RS": 26.3,
"V": 13.8,
"F": 13.6,
"OI": -100.0,
"S": null,
"IV": 85.8,
"B": null,
"Liquidity": 30.4,
"OpeningConfidence": 48.9,
"FlowAgreement": 33.3,
"StrikeBreadth": 50.0
},
"drivers": [
"- open-interest change -100",
"+ IV behaviour +86",
"+ trend +41",
"+ relative strength +26"
]
}
}
Data:
{
"vix": 14.81,
"sp500": 7704.13,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.31,
"hy_spread": 2.73,
"treasury": {
"date": "2026-09-25",
"month1": 4.04,
"month2": 4.2,
"month3": 4.24,
"month6": 4.33,
"year1": 4.5,
"year2": 4.81,
"year3": 4.94,
"year5": 4.98,
"year7": 5.06,
"year10": 5.17,
"year20": 5.54,
"year30": 5.49
},
"events": [
{
"title": "Core PCE Price Index m/m",
"currency": "USD",
"date": "2026-09-30",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.3%",
"previous": "0.2%",
"actual": null,
"minutes_until": 1410
},
{
"title": "Final GDP q/q",
"currency": "USD",
"date": "2026-09-30",
"time_utc": "12:30",
"impact": "High",
"forecast": "1.5%",
"previous": "1.5%",
"actual": null,
"minutes_until": 1410
},
{
"title": "Average Hourly Earnings m/m",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.3%",
"previous": "0.3%",
"actual": null,
"minutes_until": 4290
},
{
"title": "Non-Farm Employment Change",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "90K",
"previous": "162K",
"actual": null,
"minutes_until": 4290
},
{
"title": "Unemployment Rate",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "4.1%",
"previous": "4.1%",
"actual": null,
"minutes_until": 4290
}
]
}
Data:
{
"days": 102,
"patterns": [
{
"name": "VWAP Touch",
"count": 102,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 102,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 102,
"pct": 100
},
{
"name": "Woodie Pivot Touch",
"count": 100,
"pct": 98
},
{
"name": "ORB Breakout",
"count": 99,
"pct": 97
},
{
"name": "PDH/PDL Touch",
"count": 89,
"pct": 87
},
{
"name": "Open Retracement",
"count": 74,
"pct": 73
},
{
"name": "Gap Fill",
"count": 73,
"pct": 72
},
{
"name": "Darvas Box",
"count": 54,
"pct": 53
},
{
"name": "High Vol Open",
"count": 21,
"pct": 21
},
{
"name": "Power Hour",
"count": 14,
"pct": 14
}
]
}